STOCK TITAN

Insider sale notice at DTIL (NASDAQ: DTIL) for 4,925 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DTIL reported an insider sale notice for common stock under Form 144. The filing lists 4,925 shares as restricted stock vesting to be sold on 02/17/2026 and shows 8,854 shares sold during the prior three months on 01/21/2026. The broker listed is Fidelity Brokerage Services LLC.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does DTIL's Form 144 filing report?

The filing reports a proposed sale of 4,925 common shares related to restricted stock vesting on 02/17/2026, and prior sales of 8,854 shares on 01/21/2026. It lists Fidelity Brokerage Services LLC as the broker.

Who is the broker handling the DTIL transactions?

The filing names Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI, as the broker for the listed transactions, with the NASDAQ identifier shown in the securities information.

Which insider is associated with the DTIL Form 144 entries?

An entry lists Dario J. Scimeca with an address in Durham, NC, associated with a prior sale of 8,854 common shares on 01/21/2026 recorded in the filing.

Are the shares in DTIL's filing newly vested or previously sold?

The filing shows 4,925 shares described as restricted stock vesting to be sold on 02/17/2026, and separately documents 8,854 shares sold during the past three months on 01/21/2026.

Does the Form 144 indicate timing or conditions for execution of DTIL sales?

The filing specifies the vesting and reported sale dates (02/17/2026 and 01/21/2026) but does not state additional execution conditions or proceeds usage beyond broker and transaction type.
Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

96.29M
22.56M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
DURHAM